|
Memórias do Instituto Oswaldo Cruz
Fundação Oswaldo Cruz, Fiocruz
ISSN: 1678-8060 EISSN: 1678-8060
Vol. 91, Num. 1, 1996, pp. 37-42
|
Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 91(1),
Jan/Feb. 1996
Monoclonal Antibodies for the Identification of New World
Leishmania Species
Gabriel Grimaldi Jr, Diane McMahon-Pratt*
Departamento de Imunologia, Instituto Oswaldo Cruz, Av. Brasil
4365, 21045-900 Rio de Janeiro, RJ, Brasil *Department of
Epidemiology and Public Health, Yale University School of
Medicine, P.O. Box 3333, New Haven, CT, 06510, USA
Code Number: OC96006
Sizes of Files:
Text: 30K
No associated graphics
Monoclonal antibodies specific for selected species
complexes of Leishmania have been employed for the
characterization of several representative strains of
Leishmania isolated from different hosts and localities
in the Americas. In the past 15 years, data have been
accumulated concerning (i) the specificities of a number of
these monoclonal antibodies and (ii) the antigenic variation
(level of the expressed antigenic determinants) occurring
among New World Leishmania species or strain variants
as recognized by the monoclonal antibodies. This report is an
attempt to summarize in brief the data accumulated to date on
these points and to indicate the directions for future
applications of these specific monoclonal antibodies for
identification of leishmanial isolates.
Key words: Leishmania - serodemes - monoclonal
antibodies - radioimmune binding assay - immunotaxonomy
Monoclonal antibodies have been employed extensively for the
identification of Leishmania species, development of
diagnostic tests, investigation of molecules associated with
parasite virulence and/or pathogenicity, and in the
characterization of defined leishmanial antigens that should
be able to produce immunoprotection against human
leishmaniasis following vaccination (reviewed in Grimaldi &
Tesh 1993).
Parasitic protozoa of the genus Leishmania
(Kinetoplastida: Trypanosomatidae) are a biologically diverse
group of microorganisms (Lainson & Shaw 1987). Taxonomic
studies of Leishmania isolates from the New World
indicate tremendous diversity within this genus (Cupolillo et
al. 1994). A number of new Leishmania species have been
described recently from sylvan areas of the Neotropics
(Silveira et al. 1987, Lainson et al. 1989, Lainson & Shaw
1989, Kreutzer et al. 1991, Grimaldi et al. 1992, Yoshida et
al. 1993). Some other taxonomically distinct taxa, isolated
from wild mammals and vectors in the Brazilian Amazon Region,
have also been described as unnamed new species (Lainson &
Shaw 1987, Grimaldi et al. 1989, 1991). Much of this recent
information on the epidemiology of the various New World
Leishmania has been made through the application of
techniques employing specific monoclonal antobodies as well as
other molecular criteria for identifying and classifying
leishmanial field isolates in comparison with standard
reference strains (Saravia et al. 1985, Grimaldi et al. 1987,
1989, 1991, 1992, Aguilar et al. 1989, Yoshida et al. 1990,
Barral et al. 1991, Darce et al. 1991, Falqueto et al. 1991,
Hashiguchi et al. 1991, Kreutzer et al. 1991, Ponce et al.
1991, Bonfante-Garrido et al. 1992).
In order to determine a crosspanel of monoclonal antibodies
suitable for parasite (species) identification, the WHO
Special Programme for Research and Training on Tropical
Diseases (TDR), the Pan American Health Organization (PAHO)
and the Academia de Ciencias de America Latina, jointly
organized two meetings in Washington, D.C. (February 1993) and
Cali, Colombia (December 1993). Based upon the double blinded
testing of Leishmania monoclonal antibodies (99),
fourteen monoclonal antibodies were selected and recommended
for general use in the identification of Leishmania
species. Here we discuss the reactivities of some of these
antibodies with Leishmania group- and species-specific
antigens.
MATERIALS AND METHODS
Serodeme analysis using monoclonal antibodies - The
monoclonals that have been used for characterization and
identification of leishmanial isolates are listed elsewhere
(Grimaldi et al. 1987, 1991, Hashiguchi et al. 1991, Kreutzer
et al. 1991, Bonfante-Garrido et al. 1992). These monoclonals
that distinguish both New World and Old World species of
Leishmania were produced as reported previously
(McMahon-Pratt & David 1981, McMahon-Pratt et al. 1982, 1985,
1986, Jaffe & McMahon-Pratt 1983, Jaffe et al. 1984, Pan &
McMahon-Pratt 1988) according to the method of Kohler and
Milstein (1975) as modified by Kennett et al. (1978).
Characterization of the Leishmania was performed with
an indirect radioimmune binding assay (RIA) using whole
parasite lysates as antigen. The technique has been described
in detail before (Grimaldi et al. 1987). A subsample of the
leishmanial stocks were also analyzed by indirect
immunofluorescence (McMahon-Pratt et al. 1986) or ELISA assays
(Jaffe & McMahon-Pratt 1987) using the monoclonal antibodies.
Leishmania - Over the past 15 years, we have collected and
characterized, by species-specific monoclonal antibodies and
RIA, a large panel of leishmanial parasites. The results with
specific monoclonal antibodies on both the identification and
classification of leishmanial parasites were also confirmed,
using in parallel isoenzyme electrophoresis (including
numerical zymotaxonomic analyses) and other molecular
techniques such as analysis of restriction enzyme digestion
patterns of kinetoplast DNA and molecular karyotypes
(Grimaldi et al. 1991, 1992, Hashiguchi et al. 1991, Kreutzer
et al. 1991, Bonfante-Garrido et al. 1992, Yoshida et al.
1993, Cupolillo et al. 1994). Leishmania promastigotes
were cultured in Schneider's Drosophila Medium (Gibco, Grand
Island, NY) (Hendricks et al. 1978) supplemented with 10%
heat-inactivated fetal calf serum (Flow Laboratories, McLean,
VA) at 24 C. Parasites in the log phase of growth were
harvested by centrifugation (1,500 x g for 10 min, at 4 C) and
washed twice in phosphate-buffered saline (PBS), pH 7.3. The
final pellet was used for preparation of samples for parasite
characterization using monoclonal antibodies (Grimaldi et al.
1987).
RESULTS AND DISCUSSION
Some preliminary results on the reactivity of monoclonal
antibodies derived for selected species complexes of
Leishmania (McMahon-Pratt et al. 1982, 1985, 1986,
Jaffe & McMahon-Pratt 1983, Jaffe et al. 1984, Shaw et al.
1986, Pan & McMahon-Pratt 1988, Hanham et al. 1990) were
confirmed in our recent studies using a large sample (1,500
Leishmania stocks, isolated from humans and a variety
of mammalian and sandfly hosts) from different localities in
the New World. Included are results of our work as well as
data from other recently published studies (Grimaldi et al.
1987, 1989, 1991, Aguilar et al. 1989, Barral et al. 1991,
Darce et al. 1991, Falqueto et al. 1991, Hashiguchi et al.
1991, Kreutzer et al. 1991, Ponce et al. 1991,
Bonfante-Garrido et al. 1992).
Qualitatively, the reactivity of the monoclonal antibodies did
not show any variation related to time in culture, culture
media, or parasite virulence (Grimaldi et al. 1987). However,
variation in the sensitivity of the test may occur due to the
type of screening assay used (i.e., immunofluorescence, RIA or
the ELISA technique). As an exemple, the L. donovani
group-specific epitope recognized by monoclonal antibody D2,
using RIA (Jaffe et al. 1984, Grimaldi et al. 1987) or ELISA,
is weakly detected by IFA. However, as indicated in previous
studies (McMahon-Pratt et al. 1986, Grimaldi et al. 1987,
1991, Barral et al. 1991), independent of the origin of
Leishmania stock (i.e., host species involved or the
clinical state of the infection) or of geographic area of
isolation, some of the monoclonal antibodies showed a high and
consistent qualitative specificity at a species level. In
these analyses (see Table), the following monoclonals were the
most specific: D2 (LXXVIII, 2E5-A8) for L. (L.)
chagasi; B11 (VII-5G3-F3) for L. (V.) panamensis;
B18 (XIV-2A5-A10) for L. (V.) braziliensis; M3
(IX-5H9-C10) for L. (L.) amazonensis; and V1
(CLXXVI-3C11-F14) for L. (L.) venezuelensis. However,
significant differences between the reactivity patterns with
specific monoclonal antibodies could be observed among stocks
from certain species complexes of Leishmania from
distinct endemic areas. These differences can be related with
strain variation in the level of expression of certain
antigenic determinants, as recognized by some of the
monoclonal antibodies. For instance, Venezuelan isolates of
L. (V.) braziliensis showed a distinct profile
(Bonfante-Garrido et al. 1992) when they were compared with
the same parasite species which circulates in Bolivia, Brazil
or Colombia (Barral et al. 1991, Grimaldi et al. 1991,
Grimaldi & McMahon-Pratt, unpublished data). Also, the
species-specific epitope recognized by monoclonal antibody B19
(XLIV-5A2-B9) (Grimaldi et al. 1987) could not be detected in
some variant strains of L. (V.) guyanensis (Grimaldi
et al. 1991), indicating that they had lost the epitope. In
addition, some L. (V.) braziliensis isolates from the
Brazilian Amazon Region (Grimaldi et al. 1991), as well as
other variant strains of this parasite from Bolivia and Peru
(Grimaldi & McMahon-Pratt, unpublished data) did not react
with the specific monoclonal antibody B16 (XIII-3E6-B11) that
identify this species (Shaw et al. 1986, McMahon-Pratt et al.
1986, Grimaldi et al. 1987, Barral et al. 1991). Furthermore,
although naturally occurring hybrid parasites (L. (V.)
braziliensis x L. (V.) guyanensis) from Venezuela reacted
with the specific monoclonal antibodies (B16 and B18) for
L. (V.) braziliensis (Bonfante-Garrido et al. 1992,
Grimaldi & McMahon-Pratt, unpublished data), conflicting
results were obtained when the L. (V.) braziliensis x L.
(V.) panamensis hybrids from Nicaragua were analyzed by
the same method (Darce et al. 1991). Indeed, these monoclonals
as well as the L. (V.) panamensis-specific monoclonal
antibody (B11) did not react with the later hybrid isolates,
indicating that they had lost the epitopes specific to both
the parental species (Momen et al. 1993). On the other hand,
numerical analysis of the enzymic profiles of L. (L.)
venezuelensis isolates showed that this species was
phenetically closely related to the WHO L. (L.)
mexicana reference strain. However, these strains did not
react with any of the monoclonal antibodies group-specific for
L. mexicana complex parasites, other than the
species-specific (V1) monoclonal antibody (Bonfante-Garrido et
al. 1992).
As aforementioned, not all known species of Leishmania
are recognized by a distinct/specific monoclonal antibody
(Grimaldi et al. 1987, 1991, 1992, Kreutzer et al. 1991).
However, the patterns observed with the less specific
monoclonals (as defined by either qualitative or quantitative
reactions with the expressed antigens) are indicative of these
species. For example, monoclonal antibodies B3 (VI-4D10-D12)
and B12 (XIII-3H6-A12) were found to be useful in the
confirmation of L. (V.) braziliensis from Argentina,
Bolivia, Brazil, Colombia, Nicaragua and Peru (Grimaldi et al.
1987, Barral et al. 1991, Grimaldi & McMahon-Pratt,
unpublished data) or L. (V.) panamensis from
Colombia, Costa Rica, Ecuador, Honduras and Nicaragua
(Grimaldi et al., 1987 Grimaldi & McMahon-Pratt, unpublished
data). In contrast, these monoclonals were not reactive in RIA
tests with stocks of L. (V.) guyanensis, L. (V.) shawi, L.
(V.) lainsoni, L. (V.) colombiensis or L. (V.)
equatorensis regardless of geographic origin (Grimaldi et
al., 1991, 1992, Kreutzer et al. 1991, Bonfante-Garrido et al.
1992, Grimaldi & McMahon-Pratt, unpublished data). In
addition, although B4 (VI-2 A5-A4) crossreacted with L.
(V.) panamensis, L. (V.) colombiensis and L. (V.)
equatorensis (Kreutzer et al. 1991, Grimaldi et al. 1992),
the former species could be easily distinguished using in
conjunction the more specific monoclonal antibody (B11).
Moreover, certain of the quantitative antigenic variations
occurring betwen groups or species often exceed that detected
within each of these taxonomic groups (Grimaldi et al. 1987).
There are other unusual features about leishmaniases of the
New World. Although American cutaneous leishmaniasis is
usually caused by parasite species belonging to the L.
braziliensis or L. mexicana complex (Lainson & Shaw
1987, Grimaldi et al. 1989), a few cases of the disease from
Brazil (Momen et al. 1985) and Ecuador (Hashiguchi et al.
1991) have been associated with a parasite similar to the Old
World L. (L.) major. Interestingly, these L.
major-like parasites cross-reacted with several
monoclonal antibodies (T1, XLVI-5B8-A8; T2, XLVI-4H12-C2; T3,
XLVI-5A5-D4; T4, LXVIII-1A4-G1; and T8, LXVII-3E12-F8) (Momen
et al. 1985, Hashiguchi et al. 1991) produced against members
of the L. major or L. tropica complex (Jaffe &
McMahon-Pratt 1983). In addition, our experience would
indicate the existence of a number of other leishmanial
parasites circulating in the Americas [e.g., L. (V.)
colombiensis; L. (L.) equatorensis; and L. (L.)
venezuelensis] that also cross-reacted with the L. major
species-specific monoclonals (Kreutzer et al. 1991,
Bonfante-Garrido et al. 1992, Grimaldi et al. 1992). Work is
now in progress to better define the phylogenetic relationship
between these parasites and Old World L. (L.) major
strains. Whatever the explanation for the existence of
these L. major related parasites, the results point to
caution for all researchers working with New World
Leishmania isolates. We recommend that when classifying
these parasites, reference strains of Old World species as
well as the L. major-specific monoclonals (e.g., the
monoclonal T1, XIX-2D8-D7) be included for comparison.
Several monoclonal antibodies (D-2, B-4, B-5, B-7, B-16, B-19,
M-3, M-7, P-9, T-9) analyzed in this study were selected by
the WHO Workshops and recommended for general use in the
identification of Leishmania species. The analyses of
strains brought by the participants of the Cali Workshop also
pointed strongly to the need for the incorporation of
additional monoclonals (e.g., B-3, B-11, B-12, B-18, V-1) in
an expanded crosspanel. We should mention that a free
"Monoclonal antibody kit" for diagnosis/identification of
Leishmania species, consisting of lyophilized aliquots
(100 ul) of the monoclonal antibodies (titers 10^4 to 10^6)
will be available soon; as part of the kit, a description of
methods (immunofluorescence and the ELISA technique) will also
be provided. Requests for the kit will be made to Dr F
Modabber, World Health Organization, Geneva, Switzerland. A
formal request form indicating the potential application and
resources available for analyses will be requested by WHO.
In conclusion, problems related to the differentiation and
identification of some leishmanial parasites were encountered
using serodeme analysis with specific monoclonal antibodies,
as well as when those samples were analyzed by isoenzyme
characterization (Grimaldi et al. 1987, 1989, 1991). Some of
these isolates represent additional new species (Grimaldi et
al. 1991, 1992, Kreutzer et al. 1991) or hybrid parasites
(Darce et al. 1991, Bonfante-Garrido et al. 1992) and further
investigation with new monoclonal antibodies is recommended in
these situations. A comparison of the discriminatory ability
of the two typing methods for Leishmania using
Simpson's index of diversity showed that serodeme analysis
is more discriminating, even though the zymodeme analysis
produced more groups (Cupolillo et al. 1993). The continual
discovery of new leishmanial species in tropical America is,
in part, a reflection of the increasingly sophisticated
methods for parasite differentiation. However, it also
indicates that there has been a much greater evolutionary
divergence among this parasite group in the New World,
compared to the Old World.
REFERENCES
Aguilar CM, Rangel EF, Garcia L, Fernandez E, Momen H,
Grimaldi Jr G 1989. Zoonotic cutaneous leishmaniasis due to
Leishmania (Viannia) braziliensis associated with
domestic animals in Venezuela and Brazil. Mem Inst Oswaldo
Cruz 84: 19-20.
Barral A, Pedral-Sampaio D, Grimaldi Jr G, Momen H,
McMahon-Pratt D, Ribeiro de Jesus A, Almeida R, Badaro R,
Barral-Neto M, Carvalho EM, Johson Jr WD 1991.
Leishmaniasis in Bahia, Brazil: Evidence that
Leishmania amazonensis produces a wide spectrum of
clinical disease. Am J Trop Med Hyg 44: 536-546.
Bonfante-Garrido R, Melendez E, Barroeta S, Mejia de Alejos
MA, Momen H, Cupolillo E, Grimaldi Jr G 1992. Cutaneous
leishmaniasis in western Venezuela caused by infection with
Leishmania venezuelensis and L. braziliensis
variants. Trans R Soc Trop Med Hyg 86: 141-148.
Cupolillo E, Grimaldi Jr G, Momen H 1993. Discriminatory
ability of typing systems in Leishmania. Trans R Soc
Trop Med Hyg 87: 116-117.
Cupolillo E, Grimaldi Jr G, Momen H 1994. A general
classification of New World Leishmania using numerical
zymotaxonomy. Am J Trop Med Hyg 50: 296-311.
Darce MJ, Moran J, Palacios X, Belli A, Gomez-Urcuyo F, Zamora
D, Valle S, Gantier JC, Momen H, Grimaldi Jr G 1991. Etiology
of human cutaneous leishmaniasis in Nicaragua. Trans R Soc
Trop Med Hyg 85: 58-59.
Jaffe CL, Bennett E, Grimaldi Jr G, McMahon-Pratt D 1984.
Production and characterization of species specific monoclonal
antibodies against Leishmania donovani for
immunodiagnosis. J Immunol 133: 440-447.
Jaffe CL, McMahon-Pratt D 1983. Monoclonal antibodies specific
for Leishmania tropica. I. Characterization of antigens
associated with stage- and species-specific determinants. J
Immunol 131: 1987-1993.
Jaffe CL, McMahon-Pratt D 1987. Serogiagnostic assay for
visceral leishmaniasis employing monoclonal antibodies. Trans
R Soc Trop Med Hyg 81: 587-594.
Falqueto A, Sessa PA, Vareja~o JBM, Barros GC, Momen H,
Grimaldi Jr G 1991. Leishmaniasis due to
Leishmania braziliensis in Espirito Santo State,
Brazil. Further evidence on the role of dogs as a reservoir of
infection for humans. Mem Inst Oswaldo Cruz 86: 499-500.
Grimaldi Jr G, David JR, McMahon-Pratt D 1987.
Identification and distribution of New World Leismania species
characterized by serodeme analysis using monoclonal
antibodies. Am J Trop Med Hyg 36: 270-287.
Grimaldi Jr G, Kreutzer RD, Hashiguchi Y, Gomez EA, Mimory
T, Tesh RB 1992. Description of Leishmania
equatoriensis sp. n. (Kinetoplastida: Trypanosomatidae), a
new parasite infecting arboreal mammals in Ecuador. Mem Inst
Oswaldo Cruz 87: 221-228.
Grimaldi Jr G, Momen H, Naiff RD, McMahon-Pratt D, Barrett TV
1991. Characterization and classification of leishmanial
parasites from humans, wild mammals, and sandflies in the
Amazon Region of Brazil. Am J Trop Med Hyg 44: 645-661.
Grimaldi JrG, Tesh RB 1993. Leishmaniases of the New World:
Current concepts and implications for future research. Clin
Microbiol Rev 6: 230-250.
Grimaldi Jr G, Tesh RB, McMahon-Pratt D 1989. A review of
the geographic distribution and epidemiology of leishmaniasis
in the New world. Am J Trop Med Hyg 41: 687-725.
Hanham CA, Shaw JJ, Lainson R, McMahon-Pratt D 1990.
Production of a specific monoclonal antibody for the
identification of Leishmania (Leishmania)
venezuelensis. Am J Trop Med Hyg 42: 453-459.
Hashiguchi Y, Gomez EA, Coronel VV, Mimori T, Kawabata M,
Furuya M, Nonaka S, Takaoka H, Alexander JB, Quizpe AM,
Grimaldi Jr G, Kreutzer RD, Tesh RB 1991. Andean
leishmaniasis in Ecuador caused by infection with
Leishmania mexicana and L. major-like
parasites. Am J Trop Med Hyg 44: 205-217.
Hendricks LD, Wodd DE, Hajduk ME 1978. Haemoflagellates:
commercially available liquid media for rapid cultivation.
Parasitology 76: 309-316.
Kennett RH, Denis KA, Tung AS, Klinman NR 1978. Hybrid
plasmacytoma production: fusions with adult spleen cells,
monoclonal spleen fragments, neonatal spleen cells and human
spleen cells. Curr Top Microbiol Immunol 81: 77-86.
Kohler G, Milstein C 1975. Continuos cultures of fused cells
secreting antibody of predefined specificity. Nature 256:
495-497.
Kreutzer RD, Corredor A, Grimaldi Jr G, Grogl M, Rowton ED,
Young DG, Morales A, McMahon-Pratt D, Guzman H, Tesh RB 1991.
Characterization of Leishmania colombiensis sp. n.
(Kinetoplastida: Trypanosomatidae), a new parasite infecting
humans, animals, and phlebotomine sand flies in Colombia and
Panama. Am J Trop Med Hyg 44: 662-675.
Lainson R, Braga RR, Souza AAA, Povoa MM, Ishikawa EAY,
Silveira FT 1989. Leishmania (Viannia) shawi sp.n., a
parasite of monkeys, sloths and procyonids in Amazonian
Brazil. Ann Parasitol Hum Comp 64: 200-207.
Lainson R, Shaw JJ 1987. Evolution, classification and
geographical distribution, v. 2, p. 1-120. In W Peters, R
Killick-Kendrick (eds). The leishmaniasis in biology and
medicine. Academic Press, London.
Lainson R, Shaw JJ 1989. Leishmania (Viannia) naiffi
sp. n., a parasite of the armadillo, Dasypus novemcinctus
(L.) in Amazonian Brazil. Ann Parasitol Human Comp 61:
3-9.
McMahon-Pratt D, David JR 1981. Monoclonal antibodies that
distinguish between New World species of Leishmania.
Nature 291: 581.
McMahon-Pratt D, Bennett E, David JR 1982. Monoclonal
antibodies that distinguish subspecies of Leishmania
braziliensis. J Immunol 129: 926-927.
McMahon-Pratt D, Bennett E, Jaffe CL, Grimaldi Jr G 1985.
Subspecies and species specific antigens of Leishmania
mexicana characterized by monoclonal antibodies. J
Immunol 134: 1935-1940.
McMahon-Pratt D, Jaffe CL, Bennett E, David JR, Grimaldi Jr G
1986. Studies employing monoclonal antibodies for the analysis
of the genus Leishmania Ross, 1903, p. 173-178. In
Leishmania. Taxonomie et Phylogenese. Applications
eco-epidemiologiques (Coll Intern CNRS/INSERM, 1984). IMEEE,
Montpellier, France.
Momen H, Cupolillo E, Grimaldi Jr G 1993. Population genetics
of Leishmania in the New World, p. 188-198. In AN
Bhaduri, MK
Basu, AK Sen, S Kumar (eds). Current trends in
Leishmania research. Publications & Information
Directorate (CSIR), New Delhi, India.
Momen H, Grimaldi Jr G, Pacheco RS, Jaffe RS, McMahon-Pratt D,
Marzochi MCA 1985. Brazilian Leishmania stocks
phenotipically similar to Leishmania major. Am J Trop
Med Hyg 34: 1076-1084.
Pan AA, McMahon-Pratt D 1988. Monoclonal antibodies specific
for the amastigote stage of Leishmania pifanoi. I.
Characterization of antigens associated with stage- and
species-specific determinants. J Immunol 140: 2406-2414.
Ponce C, Ponce E, Morrison A, Cruz A, Kreutzer R,
McMahon-Pratt D, Neva F 1991. Leishmania donovani
chagasi: New clinical variant of cutaneous leishmaniasis
in Honduras. Lancet 337: 67-70.
Saravia NG, Holguin AF, McMahon-Pratt D, D'Alessandro A 1985.
Agents of mucocutaneous leishmaniasis in Colombia. Am J Trop
Med Hyg 34: 714-718.
Shaw JJ, Lainson R, McMahon-Pratt D, David JR 1986. Serodemes
of Leishmania braziliensis braziliensis and
Leishmania braziliensis guyanensis, p. 179-183. In
Leishmania. Taxonomie et Phylogenese. Applications
eco-epidemiologiques (Coll Intern CNRS/INSERM, 1984). IMEEE,
Montpellier, France.
Silveira FT, Shaw JJ, Braga RR, Ishikawa E 1987. Dermal
leishmaniasis in the Amazon Region of Brazil:
Leishmania (Viannaia) lainsoni sp.n., a new
parasite from the State of Pará. Mem Inst Oswaldo Cruz 82:
289-292.
Yoshida ELA, Correa FMA, Marques SA, Stolf HO, Dillon NL,
Momen H, Grimaldi Jr G 1990. Human, canine and equine (Equus
caballus) leishmaniasis due to Leishmania braziliensis (=
L. braziliensis braziliensis) in the South-West Region of
Sao Paulo State, Brazil. Mem Inst Oswaldo Cruz 85: 133-134.
Yoshida ELA, Cuba Cuba CA, Pacheco RS, Cupolillo E, Tavares
CC, Machado GMC, Momen H, Grimaldi Jr G 1993. Description of
Leishmania (Leishmania) forattinii sp. n., a new
parasite infecting opossums and rodents in Brazil. Mem Inst
Oswaldo Cruz 88: 397-406.
Radioimmune binding assay results, employing Leishmania
species-or group-specific monoclonal antibodies, with
representative strains of New World Leishmania
species^a
--------------------------------------------------------------
Country Monoclonal
Species^b StockCode of Origin antibodies^c
CR D2
--------------------------------------------------------------
L. chagasi MHOM/BR/74/PP75 Brazil, Bahia 9.2 8.4
L. chagasi MCAN/BR/84/C17382 Brazil, Ceara 8.9 8.3
L. chagasi MCAN/BR/82/CCG3 Brazil, R.Janeiro 8.7 11.3
L. chagasi MHOM/HN/85/H-25 Honduras 8.0 10.6
L. braziliensis MHOM/BR/75iM2903 Brazil, Para 14.3
L. braziliensis MHOM/BR/81/ALG Brazil, R.Janeiro 13.6
L. braziliensis MHOM/PE/OO/LH-15 Peru 10.4
L. braziliensis MHOM/VE/76/H-9 Venezuela 9.6
L. braziliensis^d ICAPdBR/86/IM2978 Brazil,Rondonia 6.6
L. braziliensis^e MHOM/BRJ88/IM3482 Brazil,Amazonas 15.0
L. braziliensis^f MHOM/BRI88/IM3483 Brazil,Amazonas 5.2
L. panamensis MHOM/PA/71/LS94 Panama 4.0
L. panamensis MHOM/CR/78/ICMRT72 Costa Rica 6.5
L. panamensis MHOM/HN/79/INC-4 Honduras 5.2
L. panamensis MHOM/EC/87/G-07 Ecuador 7.8
L. guyanensis MHOM/BRI75/M4147 Brazil,Para 14.4
L. guyanensis MHOM/BR/88/IM3471 Brazil, Amazonas 4.4
L. shawi MCEB/BR/84/M8408 Brazil,Para 12.0
L. naiffi MDAS/BR/78/M5169 Brazil,Para 11.8
L. lainsoni MHOM/BR/81/M6424 Brazil,Para 13.9
L. colornbiensis IHARICO/85/CL500 Colombia 9.4
L. equatorensis MHOM/EC/82/LspI Ecuador 11.3
L. amazonensis MDID/BR/87/IM3217 Brazil, Amazonas 8.5
L. amazonensis MPOT/EC/87/G-03 Ecuador, Los Rios 6.0
L. amazonensis MTAM/ECI87/G-04 Ecuador, Bolivar 5.9
L. amazonensis MHOM/VE/72/L44 Venezuela 7.8
L. mexicana MNYCJBZ/62JM379 Belize, Cayo 7.5
L. mexicana HOM/MX/83/VADYCV Mexico 6.7
L. mexicana MHOM/EC/88/Pautel Ecuador, Azuay 7.8
L. pifanoi MHOM/VE/60/LtRod Venezuela 5.8
L. venezuelensis MHOM/VET/4/PM-H3 Venezuela, Laru 4.0
L. aristidesi MORY/PA/68/GML Panama 13.4
L. foratinnii MDID/BR/77/Conch.Brazil, Sao Paulo 10.0
--------------------------------------------------------------
Monoclonal antibodies^c
Species^b B3 B4 B11 B12 B16 B18 M3 M7 VI
--------------------------------------------------------------
-
L. braziliensis 76.4 21.0 26.7 26.5
L. braziliensis 48.6 32.5 31.5 28.6
L. braziliensis 26.4 24.8 13.8 16.8
L. braziliensis 25.7 16.6 15.9
L. braziliensis^d 5.3 32.0 8.1
L. braziliensts^e 15.1 4.2
L. braziliensis^f 5.0 4.0
L.panamensis 25.0 8.4 6.7 8.9
L. panamensis 18.8 12.6 17.0 9.2
L. panamensis 17.7 11.2 13.3 6.8
L. panamensis 32.9 30.3 27.8 7.5
L. guyanensis 15.0
L. naiffi 6.2
L. equatorensis 18.4
L. amazonensis 8.6 4.6
L. amazonensis 11.3 11.2
L. amazonensis 12.6 9.9
L. amazonensis 12.0
L. mexicana 26.3
L. mexicana 5.4
L. mexicana 6.6
L. venezuelensis
6.2
--------------------------------------------------------------
a: n numbers shown are the ratios (countslmin with test
preparations) (counts/min with control preparations); see
text. Values >3 (not printed) were classed as positive
b: identification also established by isoenzyme
analysis c: prepared from the following hybridoma
clones: CR, G2DIO (this is a cross-reactive monoclonal
antibody used as positive control throughout the experiments);
D2, LXXVIII-2E5-A8; B3, VI-4D 10-D 12; B4, VI-2A5-A4; B 11,
VII-II-5G3-F3; B12, XIII-3H6-A12; B16, XIII-3E6-BII; B18,
XIV-2A5-AIO; B19, XLIV-5A2-B9; M3, IX-5H9CIO; and M7,
LXVIII-ID7-B8 d-fl. classified by numerical
zymotaxonomical analysis as distinct zymodemes (I0C-32, 10C-33
and IOC-35, respectively) or strain variants of this parasite
species (Cupolillo et al. 1994)
Recived 12 April 1995
Accepted 28 June 1995
Copyright 1995 Fundacao Oswaldo Cruz
|